Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth

BACKGROUND: A birth dose strategy using a neonatal rotavirus vaccine to target early prevention of rotavirus disease may address remaining barriers to global vaccine implementation. METHODS: We conducted a randomized, placebo-controlled trial in Indonesia to evaluate the efficacy of an oral human ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Bines, Julie E., Thobari, Jarir At, Satria, Cahya Dewi, Handley, Amanda, Watts, Emma, Cowley, Daniel, Nirwati, Hera, Ackland, James, Standish, Jane, Justice, Frances, Byars, Gabrielle, Lee, Katherine J., Barnes, Graeme L., Bachtiar, Novilia S., Icanervilia, Ajeng Viska, Boniface, Karen, Bogdanovic-Sakran, Nada, Pavlic, Daniel, Bishop, Ruth F., Kirkwood, Carl D., Buttery, Jim P., Soenarto, Yati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774175/
https://www.ncbi.nlm.nih.gov/pubmed/29466164
http://dx.doi.org/10.1056/NEJMoa1706804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774175/
https://www.ncbi.nlm.nih.gov/pubmed/29466164
http://dx.doi.org/10.1056/NEJMoa1706804

Ejemplares similares